These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 19569613

  • 21. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ, Nickerson MM, Pizzimenti CE, Kasten-Aker AG.
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [Abstract] [Full Text] [Related]

  • 22. Intravitreal triamcinolone for diffuse diabetic macular oedema.
    Longo A.
    Br J Ophthalmol; 2006 Sep; 90(9):1079-80. PubMed ID: 16929055
    [Abstract] [Full Text] [Related]

  • 23. Complications of intravitreal triamcinolone acetonide.
    Erol N, Topba S.
    Surv Ophthalmol; 2009 Sep; 54(3):427; author reply 427-8. PubMed ID: 19422973
    [No Abstract] [Full Text] [Related]

  • 24. Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema.
    Wickremasinghe SS, Rogers SL, Gillies MC, Zhu M, Wong TY.
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4707-11. PubMed ID: 18599569
    [Abstract] [Full Text] [Related]

  • 25. Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.
    Salti H, Farah T.
    Am J Ophthalmol; 2005 Nov; 140(5):958; author reply 958-9. PubMed ID: 16310498
    [No Abstract] [Full Text] [Related]

  • 26. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
    Gillies MC, Simpson JM, Gaston C, Hunt G, Ali H, Zhu M, Sutter F.
    Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
    [Abstract] [Full Text] [Related]

  • 27. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice.
    Vedantham V, Kim R.
    Indian J Ophthalmol; 2006 Jun; 54(2):133-7. PubMed ID: 16770036
    [Abstract] [Full Text] [Related]

  • 28. Intravitreal triamcinolone acetonide for diabetic macula edema.
    Loewenstein A, Goldstein M.
    Isr Med Assoc J; 2006 Jun; 8(6):426-7. PubMed ID: 16833175
    [No Abstract] [Full Text] [Related]

  • 29. Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms.
    Averbukh E, Banin E.
    Isr Med Assoc J; 2006 Feb; 8(2):127-8. PubMed ID: 16544738
    [No Abstract] [Full Text] [Related]

  • 30. Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
    Imasawa M, Ohshiro T, Gotoh T, Imai M, Iijima H.
    Acta Ophthalmol Scand; 2005 Feb; 83(1):132-3. PubMed ID: 15715582
    [No Abstract] [Full Text] [Related]

  • 31. Sterile endophthalmitis following intravitreal triamcinolone acetonide in July 2010.
    Kim M, Yu SY, Kwak HW.
    Indian J Ophthalmol; 2015 May; 63(5):467-8. PubMed ID: 26139818
    [No Abstract] [Full Text] [Related]

  • 32. Intravitreal triamcinolone.
    Stefánsson E.
    Ophthalmology; 2007 Aug; 114(8):1590; author reply 1590. PubMed ID: 17678704
    [No Abstract] [Full Text] [Related]

  • 33. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB, Unlu K, Keklikci U, Caca I, Senol BB.
    Ann Ophthalmol (Skokie); 2008 Aug; 40(3-4):190-2. PubMed ID: 19230363
    [Abstract] [Full Text] [Related]

  • 34. Intravitreal triamcinolone therapy for diabetic macular oedema.
    Vernon SA.
    Br J Ophthalmol; 2005 Aug; 89(8):931-3. PubMed ID: 16024834
    [No Abstract] [Full Text] [Related]

  • 35. Update on treatments for diabetic macular edema.
    Fraser-Bell S, Kaines A, Hykin PG.
    Curr Opin Ophthalmol; 2008 May; 19(3):185-9. PubMed ID: 18408491
    [Abstract] [Full Text] [Related]

  • 36. [Endophthalmitis following intravitreal triamcinolone acetonid injection--a case report].
    Jamrozy-Witkowska A, Grabska-Liberek I, Kowalska K, Oficjalska-Młyńczak J.
    Klin Oczna; 2010 May; 112(1-3):57-60. PubMed ID: 20572506
    [Abstract] [Full Text] [Related]

  • 37. The response pattern of intravitreal triamcinolone injection for non-AMD macular edema.
    Bhurayanontachai P, Ratanasukon M, Ma-a-lee A.
    J Med Assoc Thai; 2009 Jan; 92(1):58-63. PubMed ID: 19260245
    [Abstract] [Full Text] [Related]

  • 38. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
    Kim JE, Pollack JS, Miller DG, Mittra RA, Spaide RF, Isis Study Group.
    Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
    [Abstract] [Full Text] [Related]

  • 39. Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections.
    Lecleire-Collet A, Offret O, Gaucher D, Audren F, Haouchine B, Massin P.
    Acta Ophthalmol Scand; 2007 Nov; 85(7):795-8. PubMed ID: 17459030
    [Abstract] [Full Text] [Related]

  • 40. Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
    Quiram PA, Gonzales CR, Schwartz SD.
    Am J Ophthalmol; 2006 Mar; 141(3):580-2. PubMed ID: 16490518
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.